GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » Cyclically Adjusted PS Ratio

Medigene AG (WBO:MDG1) Cyclically Adjusted PS Ratio : 2.54 (As of Apr. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medigene AG Cyclically Adjusted PS Ratio?

As of today (2024-04-29), Medigene AG's current share price is €1.55. Medigene AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was €0.61. Medigene AG's Cyclically Adjusted PS Ratio for today is 2.54.

The historical rank and industry rank for Medigene AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:MDG1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.08   Med: 6.77   Max: 18.81
Current: 2.51

During the past 13 years, Medigene AG's highest Cyclically Adjusted PS Ratio was 18.81. The lowest was 2.08. And the median was 6.77.

WBO:MDG1's Cyclically Adjusted PS Ratio is ranked better than
67.39% of 506 companies
in the Biotechnology industry
Industry Median: 5.395 vs WBO:MDG1: 2.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medigene AG's adjusted revenue per share data of for the fiscal year that ended in Dec23 was €0.233. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.61 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medigene AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Medigene AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Cyclically Adjusted PS Ratio Chart

Medigene AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.98 6.11 4.88 2.97 2.41

Medigene AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.88 - 2.97 - 2.41

Competitive Comparison of Medigene AG's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Medigene AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigene AG's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medigene AG's Cyclically Adjusted PS Ratio falls into.



Medigene AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medigene AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.55/0.61
=2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigene AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Medigene AG's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.233/123.6675*123.6675
=0.233

Current CPI (Dec23) = 123.6675.

Medigene AG Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 1.072 99.543 1.332
201512 0.385 99.717 0.477
201612 0.464 101.217 0.567
201712 0.392 102.617 0.472
201812 0.311 104.217 0.369
201912 0.411 105.818 0.480
202012 0.309 105.518 0.362
202112 0.405 110.384 0.454
202212 1.208 119.345 1.252
202312 0.233 123.668 0.233

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medigene AG  (WBO:MDG1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medigene AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Medigene AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigene AG (WBO:MDG1) Business Description

Industry
Traded in Other Exchanges
Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (WBO:MDG1) Headlines

No Headlines